Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Using financial plans to reach life objectives can streamline your path to success. Discover how to create a plan that works for you.
22,378 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A nationwide lettuce recall disrupts menus and weighs on restaurant margins. Investors watch producers and chains as ...
A major fund boosted its Vicor stake, sending the stock higher as a 200% rally unfolds. This article unpacks the bet,...
As Deere (DE) releases its 2026 earnings outlook, investors weigh crop cycles, equipment demand, and margin trends. T...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
When Amazon signaled massive AI and data center investments, its stock tumbled. This guide explains why that drop cou...
Nvidia posted a record quarter with new revenue highs and strong guidance, signaling a shift to compute-driven growth...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
Kensho Clean Power ETF (CNRG) surged 68% over the last year but fell 9% in February, as traders await a Fed signal th...
Being first to a big-market shift can pay off, but it often costs tens of billions in dollars and investor confidence...
Oil traders confront a rare overbought signal as crude-oil futures haven’t been this overstretched in decades. Market...
Markets tremble as Iran’s leadership shift and rising oil force volatility. A JPMorgan strategist cautions against qu...